The standard TLX starts at $38,525 and the upcoming Type S will be priced above $50,000.
Johnson & Johnson plans to begin what would be the largest, late-stage trial testing a potential coronavirus vaccine in September, the company confirmed Thursday. The phase three trial would enroll up to 60,000 people, according to a J&J spokesperson and ClinicalTrials.gov. J&J’s trial would be the largest testing a coronavirus vaccine yet. Drug
Whether you’re stocking up on back-to-school clothes or searching for the best deals on baby gear like high chairs, strollers, and car seats, don’t sleep on Nordstrom’s Anniversary Sale.
Chaya Bruck, of Midwood, told WNBC that when she boarded the flight with her kids on Wednesday, her youngest child, Dina, refused to wear the mask, leading to an argument.
"We can confirm that planning and recruitment is underway for our Phase 3 program, which is subject to interim data of the Phase 1/2a trials and approval of ...
The U.S. Food and Drug Administration has cleared the way for the world’s first fully transparent surgical mask.
Gold diggers in southern Australia have found two huge nuggets worth $350,000 AUD ($250,000 USD) in historic goldfields.
As fall approaches rapidly, many are wondering if the race for a vaccine will bear fruit as early as January 2021. I am a physician-scientist and infectious diseases specialist at the University of Virginia, where I care for patients and conduct research into…
An EMT was the inspiration behind one of five American Girl dolls that honor frontline workers in the coronavirus pandemic.
Johnson & Johnson (JNJ +0.3%) is going big on its Phase 3 trial testing COVID-19 vaccine candidate, Ad26.COV2.S.